M.D. Gregory Berk - 16 Feb 2021 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role: Director
Signature: /s/ Gregory Berk
Issuer symbol: GTBP
Transactions as of: 16 Feb 2021
Net transactions value: $0
Form type: 4
Filing time: 14 Feb 2022, 16:10:00 UTC
Previous filing: 14 Feb 2022
Next filing: 19 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTBP	Common Stock	Award	$0	+278,058		$0.000000	278,058	16 Feb 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTBP	Option to purchase Common Stock	Award	$0	+50,000		$0.000000	50,000	16 Feb 2021	Common Stock	50,000	$6.33	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of shares of restricted stock ("RSAs") in connection with the reporting person's services as a director. 1/3rd of the RSAs vest on November 11, 2020, 2021 and 2022. The reporting person resigned as a director on April 23, 2021.
F2	Represents a grant of options in connection with the reporting person's services as a director. 13rd of the shares underlying the options vest on February 16, 2021, 2022 and 2023.